MAIA Biotechnology MAIA Income Statement (2021-2026)

NYSE MAIA
$1.38 +0.00 (+0.36%)
As of: Aug 21, 2026 · 10:10 AM EDT
Income Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
1.08M1.51M2.08M2.12M2.34M2.39M2.20M2.60M2.60M3.72M2.32M2.05M2.67M2.97M3.20M3.11M6.36M1.88M3.53M5.64M
Selling, General & Administrative (Quarter)
1.15M1.49M1.37M1.32M1.65M1.80M1.99M2.07M2.36M2.66M1.63M1.76M1.52M2.04M2.23M2.06M3.00M2.44M3.42M2.68M
Other Operating Expenses (Quarter)
-2.97M0.11M0.03M0.14M0.19M0.05M0.07M0.14M0.08M0.12M-4.12M-5.06M1.45M1.43M0.91M-0.18M0.46M0.69M
Operating Expenses (Quarter)
2.23M3.00M3.44M3.44M5.10M4.20M4.18M4.66M4.96M6.38M3.95M3.82M4.19M5.00M5.43M5.17M9.36M4.32M6.95M8.32M
Operating Income (Quarter)
-2.23M-3.00M-3.44M-3.44M-5.10M-4.20M-4.18M-4.66M-4.96M-6.38M-3.95M-3.82M-4.19M-5.00M-5.43M-5.17M-9.36M-4.32M-6.95M-8.32M
EBIT (Quarter)
-2.23M-3.00M-3.44M-3.44M-5.10M-4.20M-4.18M-4.66M-4.96M-6.38M-3.95M-3.82M-4.19M-5.00M-5.43M-5.17M-9.36M-4.32M-6.95M-8.32M
Non-operating items
Interest & Investment Income (Quarter)
708.00511.00472.00429.00348.00621.00336.00172.000.00M0.03M0.04M0.09M0.11M0.08M0.08M0.08M
Other Non Operating Income (Quarter)
-2.32M0.11M0.08M0.91M0.08M-0.75M0.58M0.37M
Net income details
EBT (Quarter)
-2.68M-3.00M-3.44M-20.71M-13.63M-4.20M-13.09M-6.77M-7.08M-6.35M-6.49M-15.33M-11.12M-4.92M-5.58M-5.71M-9.61M-27.20M-7.28M-8.83M
Profit After Tax (Quarter)
-5.20M-2.89M-3.41M-3.31M-4.90M-4.15M-4.12M-4.52M-4.88M-6.26M-8.07M-8.88M-2.74M-3.57M-4.52M-5.35M-8.90M-3.65M-6.37M-7.95M
Income from Non-Controlling Interests (Quarter)
-0.01M
Income from Continuing Operations (Quarter)
-2.68M-3.00M-3.44M-20.71M-13.63M-4.20M-13.09M-6.77M-7.08M-6.35M-6.49M-15.33M-11.12M-4.92M-5.58M-5.71M-9.61M-27.20M-7.28M-8.83M
Consolidated Net Income (Quarter)
-2.68M-3.00M-3.44M-20.71M-13.63M-4.20M-13.09M-6.77M-7.08M-6.35M-6.49M-15.33M-11.12M-4.92M-5.58M-5.71M-9.61M-27.20M-7.28M-8.83M
Income towards Parent Company (Quarter)
-2.68M-3.00M-3.44M-20.71M-13.63M-4.20M-13.09M-6.77M-7.08M-6.35M-6.49M-15.33M-11.12M-4.92M-5.58M-5.71M-9.61M-27.20M-7.28M-8.83M
Net Income towards Common Stockholders (Quarter)
-5.20M-2.89M-3.86M-3.31M-4.90M-4.15M-4.12M-4.52M-4.88M-6.26M-8.07M-8.88M-2.74M-4.92M-4.52M-5.35M-8.90M-3.63M-6.37M-7.94M
Additional items
EPS (Basic) (Quarter)
-1.02-0.55-0.50-0.40-0.48-0.45-0.38-0.35-0.36-0.47-0.46-0.40-0.11-0.22-0.16-0.18-0.27-0.11-0.14-0.13
EPS (Diluted) (Quarter)
-1.02-0.55-0.50-0.40-0.48-0.45-0.38-0.35-0.36-0.47-0.46-0.40-0.11-0.22-0.16-0.18-0.27-0.11-0.14-0.13
Shares Outstanding (Quarter)
5.12M5.28M7.75M8.20M10.17M9.28M10.98M12.89M13.68M13.26M17.60M22.20M23.89M22.20M27.70M30.30M33.20M32.11M45.21M60.79M
Shares Outstanding (Diluted) (Quarter)
5.12M5.28M7.75M8.20M10.17M9.28M10.98M12.89M13.68M13.26M17.60M22.20M23.89M22.20M27.70M30.30M33.20M32.11M45.21M60.79M
Shares Outstanding (Entity) (Quarter)
5.12M5.28M7.94M8.42M10.95M10.96M11.00M13.65M13.76M13.26M20.58M23.74M23.97M26.16M29.59M31.82M34.45M32.11M45.21M60.82M
EBITDA (Quarter)
-2.23M-3.00M-3.44M-3.44M-5.10M-4.20M-4.18M-4.66M-4.96M-6.38M-3.95M-3.82M-4.19M-5.00M-5.43M-5.17M-9.36M-4.32M-6.95M-8.32M
Interest Expenses (Quarter)
0.45M17.27M8.54M0.01M8.91M2.11M2.13M2.59M11.60M7.04M-28.000.24M0.63M0.25M22.88M0.33M0.51M